Equities
Saxo’s trading platform offers access to 40 stock exchanges worldwide.
Traditional equities trading offers investors units of stock in publicly traded companies whose value shifts with the company’s fortunes and which can be affected by corporate earnings releases, technical trends, cross-asset correlations, and other factors. Stock indices are weighted groupings of multiple firms – one example is the widely-traded US S&P 500 index – while exchange-traded funds, or ETFs, are marketable securities that trade in the same manner as equities while tracking the behaviour of an underlying asset such as an index, a commodity, bonds, and more.
Saxo Group's strategy team provide expert analysis of equity trends with a focus on corporate earnings, macro fundamentals, technical analysis, and cross-asset correlations. The SaxoTraderGO platform offers traders and investors access to a wide range of equities while our automated Trade Signals technology continually scans for potential equity trading opportunities based on chart patterns and success probability.
Equity trading is the exchange of company shares, derivatives, or broad stock indices, and is perhaps the highest-profile form of financial trading. Equities traders can trade instruments on major exchanges like the New York Stock Exchange, the London Stock Exchange, The Frankfurt Börse, the Tokyo Stock Exchange, or the Shanghai Stock Exchange, or on smaller exchanges like the Toronto Stock Exchange, the Johannesburg Stock Exchange, or the Copenhagen Stock Exchange.
Equity Update: China Equities Surge on Stimulus
Eleanor Creagh
Australian Market Strategist, Saxo Bank Group
Equity Update: Stocks Push Higher Despite Virus Concerns
Eleanor Creagh
Australian Market Strategist, Saxo Bank Group
Virus Cases in Hubei Jump, Maintain Optionality
Eleanor Creagh
Australian Market Strategist, Saxo Bank Group
Equities edge higher as Brent crude stress eases
Peter Garnry
Head of Equity Strategy, Saxo Bank Group
Watch global logistics shares for global supply chain signals on coronavirus
Peter Garnry
Head of Equity Strategy, Saxo Bank Group
Sanguine Approach to Virus Impact Misplaced
Eleanor Creagh
Australian Market Strategist, Saxo Bank Group
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)